Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Drug Discovery Today|October 27, 2004
Targeting JNK3 for the treatment of neurodegenerative disordersLynn Resnick, Myles Fennell
The Journal of Pharmacology and Experimental Therapeutics|April 29, 2004
Ligand dependency of 5-hydroxytryptamine 2C receptor internalizationBrian D Schlag, Zhuangwei Lou, Myles Fennell, et al.
Assay and Drug Development Technologies|August 13, 2015
High-content, full genome siRNA screen for regulators of oncogenic HRAS-driven macropinocytosisMyles Fennell, Cosimo Commisso, Craig Ramirez, et al.
Investigational New Drugs|January 4, 2018
Repurposing of the CDK inhibitor PHA-767491 as a NRF2 inhibitor drug candidate for cancer therapy via redox modulationHsiu-Yu Liu, Andrea Z Tuckett, Myles Fennell, et al.
Journal of Biomolecular Screening|August 29, 2014
Impact of RNA-guided technologies for target identification and deconvolutionMyles Fennell, Qing Xiang, Alexia Hwang, et al.
Journal of Neuroscience Methods|May 11, 2007
Screening of immunophilin ligands by quantitative analysis of neurofilament expression and neurite outgrowth in cultured neurons and cellsDanni Liu, H Beal McIlvain, Myles Fennell, et al.
Journal of Neuroscience Research|February 17, 2007
Ablation of central nervous system progenitor cells in transgenic rats using bacterial nitroreductase systemSeung P Kwak, Jessica E Malberg, David S Howland, et al.
Pageof 3